With a short trading week, all of the action was focused on the first few days of trading. Markets are looking higher from more positive news on reopening the economy and several of your positions are looking stellar!
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Automobile sales are not doing well. With everyone hating the automobile business, now is a great time to invest in tech companies with automotive exposure…
Illinois is the latest state to jump onto the billion-dollar cannabis market in an unprecedented legislative action — with more and more states eyeing this modern gold rush, the Pot market is set for a BIG summer rally…
One of the keys to biotech trading is to look for solid science. Two of our biotech’s, with their respective innovative therapies, are in a perfect position to push forward toward commercialization in U.S. That’s great news for us…
We’ve seen short attacks on cannabis companies. They’re easy pickings for short-and-distort frauds. It’s easy to throw mud at companies, especially when making claims that involve technical accounting scams that most investors simply don’t understand. I’ve seen it time and again. But this time your position did something remarkable.
COVID-19 is exposing supply chain weaknesses in the pharma industry. The effect could be greater onshoring of drug manufacturing in the future. But how will this affect our portfolio positions?
The U.S. FDA isn’t alone in breaking records this year. China’s FDA has been making big strides as well. It just approved a new drug, a drug that belongs to one of Ray’s great recommendations…